Syringe and needle exchange programs worldwide: Part II.
The first large-scale syringe and needle exchange (SANE) programs were established in The Netherlands and in the United Kingdom (UK) about 8 years ago. Since then, SANE programs have been established in Australia, Sweden, Canada, and the United States. To date, the most useful data concerning the impact of these programs have come from studies in the UK and from New Haven, San Francisco, Tacoma, and New York City in the US. Successful SANE programs require careful planning; those in charge should be familiar with the accomplishments, problems, and goals of established programs. Advance publicity and involvement of community activists, the local police precinct, and ward or district politicians are imperative for overcoming misunderstandings and prejudices and fostering a team approach. Pilot projects must be adequately funded. Other requirements include accessible facilities, convenient hours of operation (including evening hours), provision of mobile units if at all possible, and provision for sanitary disposal of discarded injection equipment in the neighborhood around the SANE programs. Programs also should have a strong evaluation component, preferably staffed by an independent university-affiliated research center. Periodic site visits are necessary to ensure that services promised in the protocol are actually delivered not only initially, but also over time. Problems with security and drug dealing in and around the building where the SANE program is located are likely, and appropriate measures should be taken to counter them.
Schwartz
R H
RH
Department of Pediatrics, Georgetown University School of Medicine, Washington, DC.
D000328:Adult; D003153:Community Health Services / Q000458:organization & administration / Q000592:standards* / Q000706:statistics & numerical data; D005260:Female; D006287:Health Planning Guidelines; D006302:Health Services Research / Q000592:standards; D006801:Humans; D008297:Male; D017146:Models, Organizational; D009339:Needles; D009426:Netherlands / Q000453:epidemiology; D009656:North America / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D010865:Pilot Projects; D015397:Program Evaluation; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000453:epidemiology; D013548:Sweden / Q000453:epidemiology; D013594:Syringes; D006113:United Kingdom / Q000453:epidemiology; D014504:Urban Health